BLP1 inhibitors are a class of chemical compounds designed to specifically target the BLP1 protein, which is a key player in various cellular regulatory processes. BLP1, also known as Bacterial Lipoprotein 1, is involved in cellular signaling pathways, particularly those related to the immune response and bacterial recognition. BLP1 is often associated with pattern recognition receptors that detect bacterial lipoproteins, helping cells to respond appropriately to external signals. Inhibitors targeting BLP1 are crafted to block its activity, thereby modulating the pathways it influences. These inhibitors are valuable in experimental research for understanding the role BLP1 plays in recognizing bacterial components and how it activates intracellular signaling cascades in response.
BLP1 inhibitors are typically small molecules that interact with specific binding domains on the BLP1 protein. By preventing BLP1 from interacting with its natural ligands or from participating in downstream signaling events, these inhibitors can disrupt its normal function, providing insights into its contribution to immune signaling and bacterial recognition. The use of BLP1 inhibitors allows researchers to study how BLP1 functions in various biological contexts, particularly in the regulation of immune cell responses to bacterial lipoproteins. These inhibitors serve as important tools for exploring the molecular mechanisms of pattern recognition and signal transduction, offering a clearer understanding of how BLP1 modulates cellular processes related to immune defense and bacterial recognition. Through controlled inhibition, scientists can dissect the specific pathways in which BLP1 is involved, advancing knowledge of its role in cellular communication and immune regulation.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylases, potentially reducing BLP1 expression by altering chromatin structure and gene accessibility. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine incorporates into DNA, inhibiting DNA methyltransferases, which may lead to hypomethylation and silencing of BLP1's gene promoter. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to GC-rich DNA sequences, possibly blocking transcription factors from accessing the BLP1 gene promoter and inhibiting its expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA, which may prevent RNA polymerase from transcribing the BLP1 gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Sirolimus binds to mTOR, potentially downregulating BLP1 expression by altering downstream protein synthesis pathways. | ||||||
Chetomin | 1403-36-7 | sc-202535 sc-202535A | 1 mg 5 mg | $186.00 $674.00 | 10 | |
Chetomin disrupts the structure of hypoxia-inducible factor 1 (HIF-1), which may decrease BLP1 expression under hypoxic conditions. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Cyclopamine inhibits the Hedgehog signaling pathway, potentially decreasing BLP1 expression related to this pathway's gene regulation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that might reduce BLP1 expression by blocking the MAPK/ERK signaling pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor and could downregulate BLP1 expression by inhibiting the AKT signaling pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor, possibly reducing BLP1 expression by inhibiting stress-related signal transduction pathways. | ||||||